Example Output: Healthcare Life Science Executive Decision Memo
Inputs used
- Project context: a clinic operations assistant that summarizes appointment preparation tasks
- Target audience: clinical operations, life science teams, patient experience, health tech PMs
- Success metric: activation, quality, and risk reduction
- Available tools and data: SOP repository, EHR export with safeguards, quality dashboard, review queue
- Desired depth: Production-ready
- Output tone: Clear operator memo
Generated Result
one-page recommendation, options table, risks, and next actions
Decision needed
The immediate decision is whether a clinic operations assistant that summarizes appointment preparation tasks is mature enough for a controlled pilot. The strongest evidence should come from workflow SOPs and de-identified notes; if either source is missing, mark the recommendation as provisional rather than filling the gap with assumptions.
Recommendation
Recommendation: run a narrow pilot before broad rollout. Prefer a governance-forward pilot if evidence suggests PHI exposure; prefer a speed-forward pilot only when de-identified notes and protocol excerpts are already reliable.
Options
Option A optimizes speed by shipping a limited workflow around protocol excerpts. Option B optimizes control by adding reviewer sign-off and rollback steps. Option C waits until evidence from quality metrics is stronger. Use the same success metric for all three options.
Evidence
Evidence to trust: quality metrics, workflow SOPs, and reviewer notes from review queue. Evidence to treat cautiously: anecdotes that are not tied to a time window, cohort, or source owner.
Risks
Treat clinical overreach as a launch blocker until there is a control that can be verified. The minimum control is: use de-identified data, plus reviewer sign-off for ambiguous outputs.
Next actions
Next actions: validate de-identified notes, assign a reviewer for PHI exposure, and schedule a decision checkpoint after the first pilot cohort. Do not expand scope until the review path works in practice.
Recommended Decision
Proceed with a narrow pilot focused on workflow SOPs and de-identified notes. Treat clinical overreach as the primary launch blocker. The first milestone should prove that the workflow produces a usable safe workflow brief, escalation rules, and audit checklist with clear evidence, named owners, and a review path for ambiguous cases.
Expected quality checks
- The result is specific to AI-assisted patient ops, protocol comprehension, life science research support, and quality review.
- It includes the required sections: Decision needed, Recommendation, Options, Evidence, Risks, Next actions.
- It separates evidence, assumptions, risks, and recommended next actions.
- It includes practical verification steps, not only generic advice.
- It names the most important failure mode for this domain: clinical overreach.
Reuse note
Before copying the output into production work, replace all default variables with your real data and run a human review for high-impact decisions.